tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market
MBRX
Moleculin Biotech
RESEARCH TOOLSreports

Moleculin Biotech (MBRX) Stock News & Sentiment

Compare
1,908 Followers
Moleculin Biotech Amends Warrants to Boost Nasdaq Compliance
Premium
Company Announcements
Moleculin Biotech Amends Warrants to Boost Nasdaq Compliance
3d ago
8K
MBRX
Buy Rating for Moleculin Biotech: Promising Progress with WP1066 in Pediatric Brain Tumors
Premium
Ratings
Buy Rating for Moleculin Biotech: Promising Progress with WP1066 in Pediatric Brain Tumors
8d ago
MBRX
Moleculin Biotech Reports Positive Phase 1 Trial Results
Premium
Company Announcements
Moleculin Biotech Reports Positive Phase 1 Trial Results
8d ago
8K
MBRX
Moleculin Biotech Regains Nasdaq Compliance
Premium
Company Announcements
Moleculin Biotech Regains Nasdaq Compliance
9d ago
8K
MBRX
Promising Progress in Moleculin Biotech’s Phase 3 MIRACLE Study Boosts Buy Rating
Premium
Ratings
Promising Progress in Moleculin Biotech’s Phase 3 MIRACLE Study Boosts Buy Rating
15d ago
MBRX
Moleculin Biotech Enters Inducement Offer Agreements
Premium
Company Announcements
Moleculin Biotech Enters Inducement Offer Agreements
15d ago
8K
MBRX
Moleculin Biotech Updates on MIRACLE Study Progress
Premium
Company Announcements
Moleculin Biotech Updates on MIRACLE Study Progress
16d ago
8K
MBRX
More MBRX News >

MBRX News on the Web

Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (MBRX) and FibroBiologics, Inc. (FBLG)
TipRanks News
Neutral
Moleculin Biotech Regains Nasdaq Compliance
TipRanks News
Neutral
Moleculin Biotech target adjusted to $31 from $300 at Roth Capital
The Fly
Neutral
Moleculin Biotech target adjusted to $22 from $4 at H.C. Wainwright
The Fly
Neutral
Moleculin Raises $6.5 Million from Warrant Exercises—Fresh Capital and New Warrants Set the Stage for 2026
Market Chameleon
Neutral
Moleculin Biotech Updates on MIRACLE Study Progress
TipRanks News
Neutral
Moleculin’s New Annamycin Brain Tumor Collaboration Targets Unmet Needs in Glioblastoma
Market Chameleon
Neutral
Upcoming Stock Splits This Week (December 1 to December 5) – Stay Invested
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
MBRX
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.5 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MBRX’s Media Buzz Sentiment?
1 articles about MBRX were published this week. In an average week, 2.5 articles are published.
    What is MBRX’s weekly average amount of articles?
    In an average week, 2.5 articles about MBRX are published.
      What is MBRX’s News Sentiment?
      50% of articles about MBRX were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        ATAIATAI Life Sciences
        ADUSAddus Homecare
        DVAXDynavax
        PDEXPro-Dex
        AGIOAgios Pharma
        Showing the stocks with the most bullish news sentiment over the past week